Only in scenarios which assumed that interventional medications were continued until death did estimated ICERs approach the upper end of what has been commonly considered cost-effectiveness threshold of 357,000 DKK (around 50,000) per QALY [53,54,55]
The drug was manufactured by Renata PLC in Bangladesh
Shi Q, Nong K, Vandvik PO, Guyatt GH, Schnell O, Rydn L, Marx N, Brosius FC, Mustafa RA, Agarwal A, Zou X
If side effects become intolerable, dose reduction is always an optionand PlexusDx providers can adjust your regimen without penalty or price change
You should not pour the medication down the drain or flush it down the toilet
doi: 10.1111/cts.13227 54 SandsBEPanaccioneRDHaensGSchreiberSJairathVDuVallAet al